Filter
1536
Filtered Results: 1536
Text search:
Cancer
surveillance
Featured
Recommendations
154
New Publications
400
Language
Document type
No document type
756
Studies & Reports
314
Guidelines
254
Strategic & Response Plan
91
Manuals
57
Fact sheets
30
Training Material
16
Situation Updates
11
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
82
India
71
Kenya
61
Western and Central Europe
36
Latin America and the Carribbean
32
Tanzania
31
Ethiopia
31
Malawi
27
Zambia
26
Africa
24
South–East Asia Region
22
South Africa
22
Ghana
21
Nigeria
21
Philippines
19
Uganda
19
Senegal
18
Burkina Faso
18
Congo, Democratic Republic of
18
Rwanda
16
Nepal
15
Ukraine
15
Benin
15
Sierra Leone
15
Bangladesh
15
Syria
13
Liberia
13
Myanmar / Burma
13
Zimbabwe
12
Lesotho
11
Haiti
11
Namibia
11
Russia
10
Indonesia
10
Cameroon
9
Niger
9
Cambodia
9
Asia
9
Eastern Europe
9
Eswatini/ Swaziland
9
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Brazil
8
Botswana
8
Colombia
7
East and Southern Africa
7
Madagascar
7
Tajikistan
5
Peru
5
Germany
5
West and Central Africa
5
Moldova
5
Sudan
5
Yemen
5
South Sudan
5
Guinea
4
Venezuela
4
Jordan
4
Paraguay
4
Argentina
4
Thailand
3
Turkey
3
Togo
3
China
3
Albania
3
Kyrgyzstan
3
Qatar
3
Mozambique
3
USA
3
Saudi Arabia
3
Western Pacific Region
3
North America
3
France
3
Bolivia
3
Lebanon
3
Georgia
3
Central African Republic
3
Libya
3
Iraq
3
Somalia
3
North Macedonia
2
Mexico
2
Kazakhstan
2
Chile
2
Iran
2
Laos
2
Bulgaria
2
Belgium
2
Spain
2
Belarus
2
Israel
2
Vietnam
2
Egypt
2
Honduras
2
Mali
2
Pakistan
2
El Salvador
1
Congo-Brazzaville
1
Afghanistan
1
Burundi
1
Morocco
1
Mauritania
1
Armenia
1
Dominican Republic
1
Hungary
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Azerbaijan
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Djibouti
1
Romania
1
Slovakia
1
Palestine
1
Poland
1
Chad
1
Ecuador
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
686
Clinical Guidelines
138
Public Health
130
Women & Child Health
52
Key Resources
46
Capacity Building
17
Pharmacy & Technologies
15
Toolboxes
COVID-19
157
HIV
111
AMR
67
TB
64
Mental Health
61
NCDs
59
Planetary Health
58
Global Health Education
39
Caregiver
37
NTDs
33
Conflict
29
Rapid Response
28
Pharmacy
26
Refugee
24
Disability
17
Ebola & Marburg
14
Specific Hazards
10
Health Financing Toolbox
10
Natural Hazards
6
Cholera
4
Zika
4
Polio
4
Social Ethics
2
Malaria
1
Public Health Risk Analysis and Surveillance
Public Health Surveillance Protocol Tuberculosis
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di...
This document outlines Rwanda's policy on non-communicable diseases. The overall goal of NCDs Policy is to alleviate the burden of NCDs and their risk factors and protect Rwandan population from premature morbidity and mortality related to NCDs. This policy was developed through a series of consulta...
This document is written for medical doctors, clinical officers, medical assistants, nurses, midwives, health surveillance assistants (HSAs), and medical records clerks who are working in public and private sector health facilities in Malawi. It is designed to be a practical guide for implementation...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
Kenya in undergoing an epidemiological transition marked by a decline in morbidity and mortality due to communicable conditions, and an increase in the burden of non-communicable diseases (NCDs), which include diseases such as diabetes, cancers, cardiovascular diseases and chronic respiratory infect...
Le COVID-19 est un nouveau coronavirus, proche de celui du Syndrome Respiratoire Aigu Sévère (SRAS) qui avait été à l’origine d’une épidémie meurtrière en 2003. L’infection par ce nouveau coronavirus se manifeste le plus souvent par une fièvre et des signes respiratoires pouvant se co...
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas...
The prevalence of chronic non-communicable diseases such as diabetes, cardiovascular diseases and cancers has been on the increase in Kenya in the recent past. This has been occasioned by changes in social and demographic situation in the country. The life expectancy...
Une fois adoptée et mise en œuvre, la stratégie contribuera à réduire sensiblement les nouvelles infections sexuellement transmissibles et les décès connexes (ainsi que les mortinatalités et le cancer du col de l’utérus), tout en améliorant la santé individuelle, la santé sexuelle des ...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Study Report August 2014
Curatio International Foundation (CIF) and the Association Tanadgoma would like to acknowledge the financial support provided by GFATM under the project “Establishment of evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in t...
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
